99%+ purity · USA shipping

Growth Hormone Secretagogues (GHS)

Research-grade lyophilized peptides. Third-party tested, COA available on request, shipped within 24 hours from our USA facility.

Growth Hormone Secretagogues (GHS)

Growth hormone secretagogues are peptides studied for their interaction with the GH/GHRH axis in endocrine research. This category features Sermorelin and CJC-1295 + Ipamorelin research blends, each supplied at 99%+ purity with a batch-specific COA. For laboratory research use only.

3rd-party tested · COA on request 24 h dispatch from USA Free shipping on orders over $150 Crypto & card checkout
Categories
All ProductsGLP-1 / Incretin Class Analogs 3Peptide Blends & Multi-Component Formulations 2Copper-Peptide Complexes 1Cytoprotective & Healing Peptides 3IGF & Insulin-Class Peptides 1Growth Hormone Secretagogues (GHS) 3Neuropeptide & CNS-Active Compounds 4Metabolic & Mitochondrial Compounds 3Melanocortin & Reproductive Peptides 3Dermatological & Cosmetic Research Reagents 1Laboratory Solutions & Consumables 2

Working out dilutions before you order? Use the free peptide reconstitution calculator to convert any vial mass and diluent volume into concentration, draw volume and U-100 syringe graduations.

Showing all 3 results

Frequently Asked Questions

What defines a growth hormone secretagogue in research terms?

The label covers compounds studied for their action on the somatotropic axis rather than for direct hormone replacement. This category includes GHRH-family analogs such as sermorelin and tesamorelin alongside the CJC-1295 and ipamorelin blend.

What is the difference between a GHRH analog and a ghrelin-receptor peptide?

They are described in the literature as acting through different receptors. Sermorelin, tesamorelin and CJC-1295 are GHRH-family sequences, while ipamorelin is characterized as a growth hormone secretagogue receptor ligand. That difference is why the two are often paired in the same experimental design.

Why does the CJC-1295 listing specify no DAC?

DAC refers to a drug affinity complex modification that extends circulating half-life in published work. The material in this catalog is the unmodified CJC-1295 sequence, sometimes written as modified GRF 1-29, and the listing states this so it is not confused with the DAC version.

How are two-component blends verified analytically?

A blended vial is characterized for each sequence rather than as a single peak. The Certificate of Analysis reports purity and identity for both components so the stated ratio can be checked before the material enters a study.